Bioventus gets FDA clearance for bone cutting tool

Bioventus’ Nexus BoneScalpel Access handpiece was cleared by the FDA.

Advertisement

The handpiece is designed for bone removal during minimally invasive surgery and to provide maximum visualization, according to a Dec. 20 news release. BoneScalpel Access is powered by the company’s ultrasonic surgical aspirator system, which has been commercialized in the U.S., Canada, Europe and Australia.

Bioventus’ BoneScalpel Access is expected to launch in 2022.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.